UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 253

Sortiert nach

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry

Journal of internal medicine, 2021-03, Vol.289 (3), p.369-384

2021

Volltextzugriff (PDF)

Amino acid ferrocene conjugates using sulfonamide linkages

Journal of organometallic chemistry, 2018-09, Vol.870, p.121-129

2018

Volltextzugriff (PDF)

Procedural Volume and Outcomes of Patients Undergoing VA-ECMO Support

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S186-S186

2020

Volltextzugriff (PDF)

Switching to Impella 5.0 Decreases Need for Transfusion in Patients Undergoing Temporary Mechanical Circulatory Support

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S419-S419

2020

Volltextzugriff (PDF)

Bridging Anti-Coagulation with Low-Molecular-Weight Heparin in HVAD Patients - A Safe and Effective Option

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S250-S250

2017

Volltextzugriff (PDF)

The predictive value of different equations for estimation of glomerular filtration rate in patients with coronary artery disease – results from the AtheroGene study

International journal of cardiology, 2016-10, Vol.221, p.908-913

2016

Volltextzugriff (PDF)

Right heart failure in pregnant women with cyanotic congenital heart disease — The good, the bad and the ugly

International journal of cardiology, 2016-01, Vol.202, p.773-775

2016

Volltextzugriff (PDF)

Different Preparations of Intravenous Immunoglobulin Vary in Their Efficacy to Neutralize Streptococcal Superantigens: Implications for Treatment of Streptococcal Toxic Shock Syndrome

Clinical infectious diseases, 2006-09, Vol.43 (6), p.743-746

2006

Volltextzugriff (PDF)

Management of Monogenic and Syndromic Obesity

Gastroenterology clinics of North America, 2023-12, Vol.52 (4), p.733-750

2023

Volltextzugriff (PDF)

Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score–Matched Analysis From the Swedish Heart Failure Registry

Circulation (New York, N.Y.), 2019-11, Vol.140 (19), p.1530-1539

2019

Volltextzugriff (PDF)

Response by Schrage et al to Letter Regarding Article, “Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry”

Circulation (New York, N.Y.), 2020-03, Vol.141 (11), p.e648-e649

2020

Volltextzugriff (PDF)

Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry

European journal of heart failure, 2021-11, Vol.23 (11), p.1844-1854

2021

Volltextzugriff (PDF)

Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry

European journal of heart failure, 2021-06, Vol.23 (6), p.1012-1022

2021

Volltextzugriff (PDF)

Incidence of hypoxic hepatitis in patients with cardiogenic shock and association with mortality

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Association of inflammation with shock severity, 30-day mortality and therapy response in patients with cardiogenic shock

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Association between a hospitalization for heart failure and the initiation/discontinuation of guideline‐recommended treatments: An analysis from the Swedish Heart Failure Registry

European journal of heart failure, 2023-07, Vol.25 (7), p.1132-1144

2023

Volltextzugriff (PDF)

Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock

ESC Heart Failure, 2021-04, Vol.8 (2), p.1295-1303

2021

Volltextzugriff (PDF)

Temporal trends, patient characteristics and hospital volume outcomes after alcohol septal ablation and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design

International journal of cardiology, 2020-08, Vol.313, p.76-82

2020

Volltextzugriff (PDF)

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality

European journal of heart failure, 2022-07, Vol.24 (7), p.1212-1222

2022

Volltextzugriff (PDF)

Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials

European journal of heart failure, 2021-11, Vol.23 (11), p.1942-1951

2021

Volltextzugriff (PDF)

Association between beta‐blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score‐matched analysis from the Swedish Heart Failure Registry

European journal of heart failure, 2020-01, Vol.22 (1), p.103-112

2020

Volltextzugriff (PDF)

Sex Differences in Clinical Characteristics and Outcomes in Patients Undergoing Heart Transplantation

The Journal of heart and lung transplantation, 2022-04, Vol.41 (4), p.S152-S152

2022

Volltextzugriff (PDF)

Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Timing of active left ventricular unloading in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(225)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(235)
Deutsch
(16)
Japanisch
(13)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry

Amino acid ferrocene conjugates using sulfonamide linkages

Procedural Volume and Outcomes of Patients Undergoing VA-ECMO Support

Switching to Impella 5.0 Decreases Need for Transfusion in Patients Undergoing Temporary Mechanical Circulatory Support

Bridging Anti-Coagulation with Low-Molecular-Weight Heparin in HVAD Patients - A Safe and Effective Option

The predictive value of different equations for estimation of glomerular filtration rate in patients with coronary artery disease – results from the AtheroGene study

Right heart failure in pregnant women with cyanotic congenital heart disease — The good, the bad and the ugly

Different Preparations of Intravenous Immunoglobulin Vary in Their Efficacy to Neutralize Streptococcal Superantigens: Implications for Treatment of Streptococcal Toxic Shock Syndrome

Management of Monogenic and Syndromic Obesity

Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score–Matched Analysis From the Swedish Heart Failure Registry

Response by Schrage et al to Letter Regarding Article, “Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry”

Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry

Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry

Incidence of hypoxic hepatitis in patients with cardiogenic shock and association with mortality

Association of inflammation with shock severity, 30-day mortality and therapy response in patients with cardiogenic shock

Association between a hospitalization for heart failure and the initiation/discontinuation of guideline‐recommended treatments: An analysis from the Swedish Heart Failure Registry

Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock

Temporal trends, patient characteristics and hospital volume outcomes after alcohol septal ablation and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy

Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design

Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality

Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials

Association between beta‐blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score‐matched analysis from the Swedish Heart Failure Registry

Sex Differences in Clinical Characteristics and Outcomes in Patients Undergoing Heart Transplantation

Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019

Timing of active left ventricular unloading in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy

Suchergebnisse filtern